Cellosaurus logo
expasy logo

Cellosaurus MelHOrPLX4032_10muM (CVCL_RQ55)

[Text version]
Cell line name MelHOrPLX4032_10muM
Synonyms Mel-HOrPLX4032_10muM; MelHOrPLX4032(10muM)
Accession CVCL_RQ55
Resource Identification Initiative To cite this cell line use: MelHOrPLX4032_10muM (RRID:CVCL_RQ55)
Comments Problematic cell line: Misidentified/contaminated. Parent cell line (Mel-Ho) was reported to be isogenic with LCL-Ho (Cellosaurus=CVCL_1868) but it does not have the same STR profile.
Part of: Resistant Cancer Cell Line (RCCL) collection.
Population: Caucasian.
Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
Derived from site: In situ; Skin; UBERON=UBERON_0002097.
Sequence variations
  • Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
Disease Melanoma (NCIt: C3224)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_1402 (Mel Ho)
Sex of cell Female
Category Cancer cell line
Publications

PubMed=22170099; DOI=10.1038/cddis.2011.129; PMCID=PMC3252738
Michaelis M., Rothweiler F., Barth S., Cinatl J., van Rikxoort M., Loschmann N., Voges Y., Breitling R., von Deimling A., Rodel F., Weber K., Fehse B., Mack E., Stiewe T., Doerr H.-W., Speidel D., Cinatl J. Jr.
Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells.
Cell Death Dis. 2:e243.1-e243.8(2011)

Cross-references
Cell line databases/resources cancercelllines; CVCL_RQ55
Encyclopedic resources Wikidata; Q54905181
Entry history
Entry creation05-Mar-2018
Last entry update19-Dec-2024
Version number8